Inclusion criteria for the prospective analysis will be (1) that the participant answered the question regarding level of OPA at the third examination and/or fourth examination (n); (2) that he or she was normotensive at examination n; and (3) that he or she participated in the BP measurement and gave a valid answer to the questions regarding antihypertensive drug usage in examination n and n+1.